| 英文名称 |
中文名称 |
CAS号 |
操作 |
| (p-SCN-Bn)-NOTA |
|
147597-66-8 |
详细
|
| NNMT-IN-4 |
|
2947393-64-6 |
详细
|
| p-SCN-Bn-DOTA |
|
127985-74-4 |
详细
|
|
|
345612-63-7 |
详细
|
|
|
841205-47-8 |
详细
|
| 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
|
170908-81-3 |
详细
|
| DOTA-mono-NHS tris(t-Bu ester) |
|
819869-77-7 |
详细
|
|
|
166734-64-1 |
详细
|
|
|
278605-15-5 |
详细
|
|
|
1198791-54-6 |
详细
|
| PT-2385 |
|
1672665-49-4 |
详细
|
| FX1;3-{5-[(3Z)-5-chloro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-4-oxo-2-thioxo-1,3-thiazol-3-yl}propanoic acid |
|
1426138-42-2 |
详细
|
|
|
198561-07-8 |
详细
|
|
|
54594-06-8 |
详细
|
|
|
1616735-65-9 |
详细
|
|
|
159766-56-0 |
详细
|
|
|
115042-85-8 |
详细
|
| 4-(3,6-dimethoxy-9H-carbazol-9-yl)benzaldehyde |
|
1280553-06-1 |
详细
|
| ERK Inhibitor |
|
1049738-54-6 |
详细
|
| N-METHACRYLOYL-L-LYSINE |
|
45158-94-9 |
详细
|
|
|
197632-76-1 |
详细
|
|
|
173935-46-1 |
详细
|
|
|
201004-29-7 |
详细
|
| 4-Aminobutyl-DOTA |
|
753421-63-5 |
详细
|
|
|
1656261-09-4 |
详细
|
|
|
104845-49-0 |
详细
|
| Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) |
|
479081-06-6 |
详细
|
|
|
1256806-34-4 |
详细
|
|
|
1191429-14-7 |
详细
|
|
|
169555-95-7 |
详细
|
|
|
148083-64-1 |
详细
|
|
|
1660127-21-8 |
详细
|
| DOTA-butyne |
|
2125661-62-1 |
详细
|
|
|
130309-37-4 |
详细
|
|
|
252049-10-8 |
详细
|
| STAT5 Inhibitor;3-{[(1E)-2-(pyridin-3-ylcarbonyl)diazanylidene]methyl}-4H-chromen-4-one |
|
285986-31-4 |
详细
|
|
|
1011309-61-7 |
详细
|
|
|
103067-79-4 |
详细
|
|
|
1427467-46-6 |
详细
|
|
|
200616-40-6 |
详细
|
| ε-N-crotonyllysine |
|
1399861-03-0 |
详细
|
|
|
951695-85-5 |
详细
|
| G6PD activator AG1 |
|
421581-52-4 |
详细
|
|
|
2227020-26-8 |
详细
|
|
|
2708163-14-6 |
详细
|
|
|
1140737-02-5 |
详细
|
| 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, Mono(4-nitrophenyl) ester |
|
474424-15-2 |
详细
|
|
|
96886-55-4 |
详细
|
| GFT505 |
|
923978-27-2 |
详细
|
|
|
201003-48-7 |
详细
|
| Fmoc-Lys-OtBu.HCl |
|
2413365-23-6 |
详细
|
| L-Lysine, N6-[(2S)-2-hydroxy-1-oxopropyl]- |
|
1227379-69-2 |
详细
|
|
|
107265-48-5 |
详细
|
|
|
112193-83-6 |
详细
|
|
|
41994-02-9 |
详细
|
| (2R)-3-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]butanoic acid |
|
191664-14-9 |
详细
|
| H-LYS(CROTONYL)-OH|H-L-LYS(CROTONYL)-OH |
|
1338823-35-0 |
详细
|
|
|
1191429-12-5 |
详细
|
|
|
1427467-44-4 |
详细
|
| (S)-3-Amino-2-(4-chloro-phenyl)-propionic acid |
|
1001227-79-7 |
详细
|
|
|
1780781-02-3 |
详细
|
|
|
386213-32-7 |
详细
|
| N-{(E)-[(tert-butoxycarbonyl)amino][(tert-butoxycarbonyl)imino]methyl}-N-methylglycine；2-[[N,N'-bis[(2-methylpropan-2-yl)oxycarbonyl]carbamimidoyl]-methylamino]acetic acid |
|
1428543-39-8 |
详细
|
|
|
823780-66-1 |
详细
|
|
|
1050501-64-8 |
详细
|
| Nε-acryloyl-L-lysin |
|
48065-82-3 |
详细
|
|
|
16338-48-0 |
详细
|
|
|
1369534-50-8 |
详细
|
| IMR-1 |
|
310456-65-6 |
详细
|
|
|
188970-92-5 |
详细
|
|
|
146987-10-2 |
详细
|
|
|
911197-00-7 |
详细
|
| (S)-tert-butyl 6-(2-bromoacetamido)-2-((tert-butoxycarbonyl)amino)hexanoate |
|
2376739-64-7 |
详细
|
| (S,E)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-but-2-enamidohexanoic acid；Fmoc-Lys(Crotonyl)-OH；(2S)-6-[[(E)-but-2-enoyl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid |
|
1245942-53-3 |
详细
|
| 4-hydroxymethylphenylalanine |
|
15742-88-8 |
详细
|
|
|
201004-46-8 |
详细
|
|
|
133174-15-9 |
详细
|
|
|
1301706-40-0 |
详细
|
|
|
159610-89-6 |
详细
|
|
|
52685-16-2 |
详细
|
|
|
75396-30-4 |
详细
|
|
|
136271-81-3 |
详细
|
| 1-METHYLHISTAMINE DIHYDROCHLORIDE |
|
6481-48-7 |
详细
|
|
|
58111-94-7 |
详细
|
| DOTA-p-NH2-Bn-(COOt-Bu)4 |
|
446061-19-4 |
详细
|
|
|
1260247-50-4 |
详细
|
|
|
2374782-04-2 |
详细
|
|
|
158478-81-0 |
详细
|
|
|
118584-90-0 |
详细
|
|
|
180978-54-5 |
详细
|
|
|
169158-05-8 |
详细
|
|
|
1440903-11-6 |
详细
|
|
|
268564-10-9 |
详细
|
|
|
924307-76-6 |
详细
|
|
|
2229230-46-8 |
详细
|
|
|
1266666-04-9 |
详细
|
| 3-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]butanoic acid |
|
1233517-91-3 |
详细
|
|
|
130855-57-1 |
详细
|
| ARN-5187 |
|
1287451-26-6 |
详细
|
| 4-Isoxazolecarboxamide, N-[4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-3,5-dimethyl- |
|
245747-10-8 |
详细
|